nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Docetaxel—stomach cancer	0.141	0.204	CbGbCtD
Olmesartan—SLCO1B1—Irinotecan—stomach cancer	0.112	0.162	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—stomach cancer	0.102	0.147	CbGbCtD
Olmesartan—ABCC2—Irinotecan—stomach cancer	0.0982	0.143	CbGbCtD
Olmesartan—ABCC2—Docetaxel—stomach cancer	0.072	0.104	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—stomach cancer	0.0591	0.0859	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—stomach cancer	0.0536	0.0779	CbGbCtD
Olmesartan—ABCC2—Methotrexate—stomach cancer	0.052	0.0754	CbGbCtD
Olmesartan—ABCC2—bile—stomach cancer	0.0127	0.263	CbGeAlD
Olmesartan—AGTR1—blood vessel—stomach cancer	0.00516	0.107	CbGeAlD
Olmesartan—Tasosartan—AGTR2—stomach cancer	0.00497	0.576	CrCbGaD
Olmesartan—AGTR1—hematopoietic system—stomach cancer	0.00275	0.0571	CbGeAlD
Olmesartan—SLCO1B1—hematopoietic system—stomach cancer	0.00262	0.0545	CbGeAlD
Olmesartan—SLCO1B3—endocrine gland—stomach cancer	0.0026	0.0541	CbGeAlD
Olmesartan—AGTR1—epithelium—stomach cancer	0.00251	0.0522	CbGeAlD
Olmesartan—AGTR1—smooth muscle tissue—stomach cancer	0.00242	0.0503	CbGeAlD
Olmesartan—SLCO1B3—liver—stomach cancer	0.00235	0.0488	CbGeAlD
Olmesartan—AGTR1—lymphoid tissue—stomach cancer	0.00194	0.0402	CbGeAlD
Olmesartan—Irbesartan—JUN—stomach cancer	0.00183	0.212	CrCbGaD
Olmesartan—SLCO1B1—digestive system—stomach cancer	0.00182	0.0379	CbGeAlD
Olmesartan—AGTR1—endocrine gland—stomach cancer	0.00158	0.0328	CbGeAlD
Olmesartan—SLCO1B1—endocrine gland—stomach cancer	0.00151	0.0313	CbGeAlD
Olmesartan—AGTR1—liver—stomach cancer	0.00142	0.0296	CbGeAlD
Olmesartan—ABCC2—digestive system—stomach cancer	0.00138	0.0287	CbGeAlD
Olmesartan—SLCO1B1—liver—stomach cancer	0.00136	0.0282	CbGeAlD
Olmesartan—ABCC2—endocrine gland—stomach cancer	0.00114	0.0237	CbGeAlD
Olmesartan—AGTR1—lymph node—stomach cancer	0.00109	0.0227	CbGeAlD
Olmesartan—ABCC2—liver—stomach cancer	0.00103	0.0214	CbGeAlD
Olmesartan—Telmisartan—PPARG—stomach cancer	0.000884	0.102	CrCbGaD
Olmesartan—ABCC2—lymph node—stomach cancer	0.000789	0.0164	CbGeAlD
Olmesartan—Losartan—ACE—stomach cancer	0.000422	0.0489	CrCbGaD
Olmesartan—Valsartan—ALB—stomach cancer	0.000354	0.041	CrCbGaD
Olmesartan—Skin disorder—Docetaxel—stomach cancer	0.00019	0.000929	CcSEcCtD
Olmesartan—Oedema—Capecitabine—stomach cancer	0.000189	0.000926	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—stomach cancer	0.000188	0.00092	CcSEcCtD
Olmesartan—Infection—Capecitabine—stomach cancer	0.000188	0.00092	CcSEcCtD
Olmesartan—Dizziness—Irinotecan—stomach cancer	0.000187	0.000914	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—stomach cancer	0.000186	0.000912	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—stomach cancer	0.000186	0.000911	CcSEcCtD
Olmesartan—Shock—Capecitabine—stomach cancer	0.000186	0.000911	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—stomach cancer	0.000186	0.00091	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—stomach cancer	0.000186	0.000909	CcSEcCtD
Olmesartan—Nervous system disorder—Capecitabine—stomach cancer	0.000186	0.000908	CcSEcCtD
Olmesartan—Diarrhoea—Fluorouracil—stomach cancer	0.000185	0.000906	CcSEcCtD
Olmesartan—Thrombocytopenia—Capecitabine—stomach cancer	0.000185	0.000906	CcSEcCtD
Olmesartan—Tachycardia—Capecitabine—stomach cancer	0.000185	0.000903	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—stomach cancer	0.000184	0.000901	CcSEcCtD
Olmesartan—Skin disorder—Capecitabine—stomach cancer	0.000184	0.000899	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—stomach cancer	0.000183	0.000896	CcSEcCtD
Olmesartan—Hyperhidrosis—Capecitabine—stomach cancer	0.000183	0.000895	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—stomach cancer	0.000183	0.000894	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—stomach cancer	0.000183	0.000893	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—stomach cancer	0.000182	0.000892	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—stomach cancer	0.000182	0.000892	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—stomach cancer	0.000182	0.00089	CcSEcCtD
Olmesartan—Anorexia—Capecitabine—stomach cancer	0.00018	0.000882	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—stomach cancer	0.00018	0.00088	CcSEcCtD
Olmesartan—Vomiting—Irinotecan—stomach cancer	0.00018	0.000879	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—stomach cancer	0.000179	0.000878	CcSEcCtD
Olmesartan—Dizziness—Fluorouracil—stomach cancer	0.000179	0.000876	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—stomach cancer	0.000179	0.000874	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—stomach cancer	0.000178	0.000873	CcSEcCtD
Olmesartan—Rash—Irinotecan—stomach cancer	0.000178	0.000872	CcSEcCtD
Olmesartan—Dermatitis—Irinotecan—stomach cancer	0.000178	0.000871	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000178	0.000871	CcSEcCtD
Olmesartan—Headache—Irinotecan—stomach cancer	0.000177	0.000866	CcSEcCtD
Olmesartan—Hypotension—Capecitabine—stomach cancer	0.000177	0.000865	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—stomach cancer	0.000177	0.000865	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—stomach cancer	0.000175	0.000857	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—stomach cancer	0.000174	0.00085	CcSEcCtD
Olmesartan—Losartan—ALB—stomach cancer	0.000173	0.02	CrCbGaD
Olmesartan—Malnutrition—Methotrexate—stomach cancer	0.000173	0.000844	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000172	0.000843	CcSEcCtD
Olmesartan—Vomiting—Fluorouracil—stomach cancer	0.000172	0.000842	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—stomach cancer	0.000172	0.000842	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—stomach cancer	0.000172	0.000842	CcSEcCtD
Olmesartan—Insomnia—Capecitabine—stomach cancer	0.000171	0.000837	CcSEcCtD
Olmesartan—Rash—Fluorouracil—stomach cancer	0.000171	0.000835	CcSEcCtD
Olmesartan—Dermatitis—Fluorouracil—stomach cancer	0.000171	0.000834	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—stomach cancer	0.00017	0.000833	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—stomach cancer	0.00017	0.000831	CcSEcCtD
Olmesartan—Headache—Fluorouracil—stomach cancer	0.00017	0.00083	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—stomach cancer	0.000169	0.000829	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—stomach cancer	0.000169	0.000827	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000169	0.000825	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—stomach cancer	0.000169	0.000825	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—stomach cancer	0.000168	0.000824	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—stomach cancer	0.000168	0.000823	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—stomach cancer	0.000168	0.000823	CcSEcCtD
Olmesartan—Nausea—Irinotecan—stomach cancer	0.000168	0.000821	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—stomach cancer	0.000167	0.000818	CcSEcCtD
Olmesartan—Constipation—Docetaxel—stomach cancer	0.000167	0.000818	CcSEcCtD
Olmesartan—Pain—Docetaxel—stomach cancer	0.000167	0.000818	CcSEcCtD
Olmesartan—Back pain—Methotrexate—stomach cancer	0.000167	0.000817	CcSEcCtD
Olmesartan—Dyspepsia—Capecitabine—stomach cancer	0.000167	0.000815	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—stomach cancer	0.000166	0.000811	CcSEcCtD
Olmesartan—Decreased appetite—Capecitabine—stomach cancer	0.000164	0.000805	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—stomach cancer	0.000164	0.000802	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000163	0.000799	CcSEcCtD
Olmesartan—Fatigue—Capecitabine—stomach cancer	0.000163	0.000798	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—stomach cancer	0.000163	0.000796	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—stomach cancer	0.000163	0.000795	CcSEcCtD
Olmesartan—Constipation—Capecitabine—stomach cancer	0.000162	0.000791	CcSEcCtD
Olmesartan—Pain—Capecitabine—stomach cancer	0.000162	0.000791	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—stomach cancer	0.000161	0.00079	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—stomach cancer	0.000161	0.000788	CcSEcCtD
Olmesartan—Nausea—Fluorouracil—stomach cancer	0.000161	0.000787	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—stomach cancer	0.00016	0.000783	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—stomach cancer	0.00016	0.000782	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—stomach cancer	0.000159	0.00078	CcSEcCtD
Olmesartan—Back pain—Epirubicin—stomach cancer	0.000156	0.000764	CcSEcCtD
Olmesartan—Feeling abnormal—Capecitabine—stomach cancer	0.000156	0.000763	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—stomach cancer	0.000156	0.000762	CcSEcCtD
Olmesartan—Malaise—Methotrexate—stomach cancer	0.000156	0.000761	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—stomach cancer	0.000155	0.00076	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—stomach cancer	0.000155	0.000759	CcSEcCtD
Olmesartan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000155	0.000757	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—stomach cancer	0.000155	0.000757	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—stomach cancer	0.000154	0.000756	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—stomach cancer	0.000154	0.000756	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—stomach cancer	0.000154	0.000756	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—stomach cancer	0.000153	0.00075	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—stomach cancer	0.000152	0.000745	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—stomach cancer	0.000152	0.000742	CcSEcCtD
Olmesartan—Cough—Methotrexate—stomach cancer	0.000151	0.000737	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—stomach cancer	0.00015	0.000736	CcSEcCtD
Olmesartan—Urticaria—Capecitabine—stomach cancer	0.00015	0.000735	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—stomach cancer	0.00015	0.000733	CcSEcCtD
Olmesartan—Abdominal pain—Capecitabine—stomach cancer	0.00015	0.000732	CcSEcCtD
Olmesartan—Body temperature increased—Capecitabine—stomach cancer	0.00015	0.000732	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—stomach cancer	0.000149	0.000731	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—stomach cancer	0.000149	0.00073	CcSEcCtD
Olmesartan—Agitation—Epirubicin—stomach cancer	0.000148	0.000726	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—stomach cancer	0.000147	0.000719	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—stomach cancer	0.000147	0.000719	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—stomach cancer	0.000147	0.000719	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000146	0.000714	CcSEcCtD
Olmesartan—Malaise—Epirubicin—stomach cancer	0.000146	0.000712	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—stomach cancer	0.000145	0.00071	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—stomach cancer	0.000145	0.00071	CcSEcCtD
Olmesartan—Syncope—Epirubicin—stomach cancer	0.000145	0.000709	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—stomach cancer	0.000145	0.000707	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—stomach cancer	0.000145	0.000707	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—stomach cancer	0.000144	0.000703	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—stomach cancer	0.000143	0.000698	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—stomach cancer	0.000142	0.000694	CcSEcCtD
Olmesartan—Cough—Epirubicin—stomach cancer	0.000141	0.000689	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—stomach cancer	0.000141	0.000689	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—stomach cancer	0.000141	0.000689	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—stomach cancer	0.00014	0.000686	CcSEcCtD
Olmesartan—Infection—Methotrexate—stomach cancer	0.00014	0.000685	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000139	0.000678	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—stomach cancer	0.000138	0.000676	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—stomach cancer	0.000138	0.000676	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—stomach cancer	0.000138	0.000676	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—stomach cancer	0.000138	0.000675	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—stomach cancer	0.000137	0.000673	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—stomach cancer	0.000137	0.000673	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—stomach cancer	0.000137	0.000673	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—stomach cancer	0.000137	0.000672	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—stomach cancer	0.000137	0.00067	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—stomach cancer	0.000137	0.000669	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000137	0.000668	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—stomach cancer	0.000136	0.000666	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—stomach cancer	0.000136	0.000665	CcSEcCtD
Olmesartan—Asthenia—Capecitabine—stomach cancer	0.000136	0.000664	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—stomach cancer	0.000135	0.000659	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—stomach cancer	0.000134	0.000657	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—stomach cancer	0.000134	0.000657	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—stomach cancer	0.000134	0.000656	CcSEcCtD
Olmesartan—Pruritus—Capecitabine—stomach cancer	0.000134	0.000655	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—stomach cancer	0.000134	0.000654	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—stomach cancer	0.000134	0.000654	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—stomach cancer	0.000132	0.000646	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—stomach cancer	0.000132	0.000645	CcSEcCtD
Olmesartan—Oedema—Epirubicin—stomach cancer	0.000132	0.000645	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—stomach cancer	0.000132	0.000644	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—stomach cancer	0.000131	0.000643	CcSEcCtD
Olmesartan—Infection—Epirubicin—stomach cancer	0.000131	0.000641	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—AGTR2—stomach cancer	0.000131	0.00261	CbGpPWpGaD
Olmesartan—Cough—Doxorubicin—stomach cancer	0.00013	0.000638	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—GMPR2—stomach cancer	0.00013	0.0026	CbGpPWpGaD
Olmesartan—Shock—Epirubicin—stomach cancer	0.00013	0.000634	CcSEcCtD
Olmesartan—Diarrhoea—Capecitabine—stomach cancer	0.000129	0.000633	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—F2R—stomach cancer	0.000129	0.00259	CbGpPWpGaD
Olmesartan—Nervous system disorder—Epirubicin—stomach cancer	0.000129	0.000632	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—stomach cancer	0.000129	0.000632	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—stomach cancer	0.000129	0.000631	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—stomach cancer	0.000129	0.000629	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000128	0.000628	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—stomach cancer	0.000128	0.000626	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—stomach cancer	0.000127	0.000623	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—stomach cancer	0.000127	0.000623	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—HRH4—stomach cancer	0.000127	0.00254	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—GSTM1—stomach cancer	0.000127	0.00254	CbGpPWpGaD
Olmesartan—Myalgia—Doxorubicin—stomach cancer	0.000127	0.000622	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—stomach cancer	0.000127	0.000622	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—stomach cancer	0.000127	0.000622	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—TNF—stomach cancer	0.000127	0.00253	CbGpPWpGaD
Olmesartan—Anxiety—Doxorubicin—stomach cancer	0.000127	0.00062	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000126	0.000618	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—HTR1A—stomach cancer	0.000126	0.00252	CbGpPWpGaD
Olmesartan—Discomfort—Doxorubicin—stomach cancer	0.000126	0.000615	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—stomach cancer	0.000126	0.000615	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000126	0.00251	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000125	0.0025	CbGpPWpGaD
Olmesartan—Dizziness—Capecitabine—stomach cancer	0.000125	0.000612	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—stomach cancer	0.000124	0.000608	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000124	0.00248	CbGpPWpGaD
Olmesartan—Dyspepsia—Methotrexate—stomach cancer	0.000124	0.000607	CcSEcCtD
Olmesartan—Rash—Docetaxel—stomach cancer	0.000123	0.000603	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—stomach cancer	0.000123	0.000603	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—stomach cancer	0.000123	0.000602	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—stomach cancer	0.000122	0.000599	CcSEcCtD
Olmesartan—Headache—Docetaxel—stomach cancer	0.000122	0.000599	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000122	0.000597	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—stomach cancer	0.000122	0.000597	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—ANXA1—stomach cancer	0.000122	0.00243	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000122	0.000595	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—stomach cancer	0.000121	0.000594	CcSEcCtD
Olmesartan—Infection—Doxorubicin—stomach cancer	0.000121	0.000593	CcSEcCtD
Olmesartan—Pain—Methotrexate—stomach cancer	0.00012	0.000589	CcSEcCtD
Olmesartan—Vomiting—Capecitabine—stomach cancer	0.00012	0.000588	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00012	0.000587	CcSEcCtD
Olmesartan—Shock—Doxorubicin—stomach cancer	0.00012	0.000587	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—stomach cancer	0.00012	0.000585	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000119	0.000584	CcSEcCtD
Olmesartan—Rash—Capecitabine—stomach cancer	0.000119	0.000584	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—stomach cancer	0.000119	0.000583	CcSEcCtD
Olmesartan—Dermatitis—Capecitabine—stomach cancer	0.000119	0.000583	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—stomach cancer	0.000119	0.000582	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—IDH3B—stomach cancer	0.000119	0.00238	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SUCLG1—stomach cancer	0.000119	0.00238	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000119	0.00238	CbGpPWpGaD
Olmesartan—Headache—Capecitabine—stomach cancer	0.000118	0.00058	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—stomach cancer	0.000118	0.00058	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000118	0.000577	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—ADRB1—stomach cancer	0.000118	0.00235	CbGpPWpGaD
Olmesartan—Anorexia—Doxorubicin—stomach cancer	0.000116	0.000569	CcSEcCtD
Olmesartan—Nausea—Docetaxel—stomach cancer	0.000116	0.000568	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—stomach cancer	0.000116	0.000568	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—stomach cancer	0.000116	0.000568	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—HRH4—stomach cancer	0.000116	0.00231	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000116	0.00231	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Methotrexate—stomach cancer	0.000115	0.000563	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—stomach cancer	0.000115	0.000561	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—stomach cancer	0.000114	0.000558	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000114	0.000557	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—stomach cancer	0.000114	0.000556	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—KISS1—stomach cancer	0.000113	0.00227	CbGpPWpGaD
Olmesartan—Pain—Epirubicin—stomach cancer	0.000113	0.000551	CcSEcCtD
Olmesartan—Constipation—Epirubicin—stomach cancer	0.000113	0.000551	CcSEcCtD
Olmesartan—Nausea—Capecitabine—stomach cancer	0.000112	0.00055	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—stomach cancer	0.000112	0.000547	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—stomach cancer	0.000111	0.000545	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—stomach cancer	0.000111	0.000545	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000111	0.000544	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—NDUFS1—stomach cancer	0.000111	0.00221	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NDUFV1—stomach cancer	0.000111	0.00221	CbGpPWpGaD
Olmesartan—Insomnia—Doxorubicin—stomach cancer	0.00011	0.00054	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—stomach cancer	0.000109	0.000531	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000108	0.00216	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000108	0.000527	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—stomach cancer	0.000107	0.000525	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—stomach cancer	0.000106	0.000519	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000105	0.000515	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—stomach cancer	0.000105	0.000514	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—stomach cancer	0.000105	0.000512	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—stomach cancer	0.000104	0.00051	CcSEcCtD
Olmesartan—Pain—Doxorubicin—stomach cancer	0.000104	0.00051	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—stomach cancer	0.000104	0.00051	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—stomach cancer	0.000104	0.00051	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000103	0.00206	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KISS1—stomach cancer	0.000103	0.00206	CbGpPWpGaD
Olmesartan—Asthenia—Methotrexate—stomach cancer	0.000101	0.000494	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—stomach cancer	0.0001	0.000492	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—stomach cancer	9.97e-05	0.000488	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—stomach cancer	9.96e-05	0.000487	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—BLVRB—stomach cancer	9.86e-05	0.00197	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PGLS—stomach cancer	9.86e-05	0.00197	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACAD8—stomach cancer	9.8e-05	0.00196	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GAST—stomach cancer	9.76e-05	0.00195	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RGS2—stomach cancer	9.76e-05	0.00195	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	9.7e-05	0.00194	CbGpPWpGaD
Olmesartan—Urticaria—Doxorubicin—stomach cancer	9.69e-05	0.000474	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—stomach cancer	9.64e-05	0.000472	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—stomach cancer	9.64e-05	0.000472	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—stomach cancer	9.63e-05	0.000471	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	9.58e-05	0.00191	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—ADRB2—stomach cancer	9.54e-05	0.00191	CbGpPWpGaD
Olmesartan—Asthenia—Epirubicin—stomach cancer	9.45e-05	0.000463	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—KISS1R—stomach cancer	9.45e-05	0.00189	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GLI3—stomach cancer	9.45e-05	0.00189	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPAP2A—stomach cancer	9.4e-05	0.00188	CbGpPWpGaD
Olmesartan—Pruritus—Epirubicin—stomach cancer	9.32e-05	0.000456	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—stomach cancer	9.31e-05	0.000456	CcSEcCtD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	9.11e-05	0.00182	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	9.04e-05	0.00181	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—stomach cancer	9.02e-05	0.0018	CbGpPWpGaD
Olmesartan—Diarrhoea—Epirubicin—stomach cancer	9.02e-05	0.000441	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—RBP1—stomach cancer	9.01e-05	0.0018	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	9.01e-05	0.0018	CbGpPWpGaD
Olmesartan—Vomiting—Methotrexate—stomach cancer	8.95e-05	0.000438	CcSEcCtD
Olmesartan—Rash—Methotrexate—stomach cancer	8.88e-05	0.000434	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—stomach cancer	8.87e-05	0.000434	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—GAST—stomach cancer	8.86e-05	0.00177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RGS2—stomach cancer	8.86e-05	0.00177	CbGpPWpGaD
Olmesartan—Headache—Methotrexate—stomach cancer	8.82e-05	0.000432	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—stomach cancer	8.75e-05	0.000428	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—GMPR2—stomach cancer	8.74e-05	0.00175	CbGpPWpGaD
Olmesartan—Dizziness—Epirubicin—stomach cancer	8.71e-05	0.000426	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—stomach cancer	8.63e-05	0.000422	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	8.44e-05	0.00169	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FBP1—stomach cancer	8.38e-05	0.00167	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CA1—stomach cancer	8.38e-05	0.00167	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NDUFA2—stomach cancer	8.38e-05	0.00167	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CKB—stomach cancer	8.38e-05	0.00167	CbGpPWpGaD
Olmesartan—Vomiting—Epirubicin—stomach cancer	8.38e-05	0.00041	CcSEcCtD
Olmesartan—Nausea—Methotrexate—stomach cancer	8.36e-05	0.000409	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—stomach cancer	8.34e-05	0.000408	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	8.34e-05	0.00167	CbGpPWpGaD
Olmesartan—Rash—Epirubicin—stomach cancer	8.31e-05	0.000407	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—stomach cancer	8.3e-05	0.000406	CcSEcCtD
Olmesartan—Headache—Epirubicin—stomach cancer	8.26e-05	0.000404	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—stomach cancer	8.06e-05	0.000395	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism—IDH3B—stomach cancer	7.99e-05	0.0016	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SUCLG1—stomach cancer	7.99e-05	0.0016	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLIN2—stomach cancer	7.88e-05	0.00157	CbGpPWpGaD
Olmesartan—Nausea—Epirubicin—stomach cancer	7.83e-05	0.000383	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—stomach cancer	7.75e-05	0.000379	CcSEcCtD
Olmesartan—Rash—Doxorubicin—stomach cancer	7.69e-05	0.000376	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—stomach cancer	7.68e-05	0.000376	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—CA2—stomach cancer	7.66e-05	0.00153	CbGpPWpGaD
Olmesartan—Headache—Doxorubicin—stomach cancer	7.64e-05	0.000374	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism—PGAM1—stomach cancer	7.47e-05	0.00149	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NT5E—stomach cancer	7.47e-05	0.00149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NDUFV1—stomach cancer	7.43e-05	0.00148	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NDUFS1—stomach cancer	7.43e-05	0.00148	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGTR2—stomach cancer	7.39e-05	0.00148	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—WWOX—stomach cancer	7.35e-05	0.00147	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2R—stomach cancer	7.31e-05	0.00146	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	7.26e-05	0.00145	CbGpPWpGaD
Olmesartan—Nausea—Doxorubicin—stomach cancer	7.24e-05	0.000354	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—stomach cancer	7.22e-05	0.00144	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLCE1—stomach cancer	7.13e-05	0.00142	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDH7A1—stomach cancer	7.13e-05	0.00142	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—HTR1A—stomach cancer	7.12e-05	0.00142	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ANXA1—stomach cancer	6.87e-05	0.00137	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—UMPS—stomach cancer	6.83e-05	0.00137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRH4—stomach cancer	6.83e-05	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—WIF1—stomach cancer	6.83e-05	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGTR2—stomach cancer	6.71e-05	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB1—stomach cancer	6.66e-05	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2R—stomach cancer	6.64e-05	0.00133	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BLVRB—stomach cancer	6.62e-05	0.00132	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PGLS—stomach cancer	6.62e-05	0.00132	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HTR1A—stomach cancer	6.46e-05	0.00129	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PDHA1—stomach cancer	6.35e-05	0.00127	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ECHS1—stomach cancer	6.35e-05	0.00127	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPAP2A—stomach cancer	6.32e-05	0.00126	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKAB1—stomach cancer	6.3e-05	0.00126	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	6.28e-05	0.00126	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ANXA1—stomach cancer	6.24e-05	0.00125	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—stomach cancer	6.11e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KISS1—stomach cancer	6.09e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RNF43—stomach cancer	6.09e-05	0.00122	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.07e-05	0.00121	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	6.05e-05	0.00121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRB1—stomach cancer	6.05e-05	0.00121	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	5.98e-05	0.00119	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	5.98e-05	0.00119	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TYMP—stomach cancer	5.97e-05	0.00119	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FADS1—stomach cancer	5.97e-05	0.00119	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PIK3CA—stomach cancer	5.8e-05	0.00116	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	5.64e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CKB—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA1—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NDUFA2—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FBP1—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SREBF2—stomach cancer	5.59e-05	0.00112	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—RORA—stomach cancer	5.53e-05	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FST—stomach cancer	5.42e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADRB2—stomach cancer	5.39e-05	0.00108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HBEGF—stomach cancer	5.31e-05	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLIN2—stomach cancer	5.29e-05	0.00106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RGS2—stomach cancer	5.23e-05	0.00105	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAST—stomach cancer	5.23e-05	0.00105	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	5.19e-05	0.00104	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALDOB—stomach cancer	5.18e-05	0.00103	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CA2—stomach cancer	5.15e-05	0.00103	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NT5E—stomach cancer	5.02e-05	0.001	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PGAM1—stomach cancer	5.02e-05	0.001	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGG—stomach cancer	4.96e-05	0.000992	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADRB2—stomach cancer	4.9e-05	0.000979	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.88e-05	0.000976	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.87e-05	0.000973	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—stomach cancer	4.85e-05	0.00097	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALOX5—stomach cancer	4.81e-05	0.000962	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PPP2R1A—stomach cancer	4.8e-05	0.000959	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	4.8e-05	0.000959	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDH7A1—stomach cancer	4.79e-05	0.000957	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCE1—stomach cancer	4.79e-05	0.000957	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKAA1—stomach cancer	4.78e-05	0.000954	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—DPYD—stomach cancer	4.74e-05	0.000946	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—stomach cancer	4.63e-05	0.000926	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RBP4—stomach cancer	4.61e-05	0.000922	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—stomach cancer	4.61e-05	0.000921	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.59e-05	0.000918	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UMPS—stomach cancer	4.59e-05	0.000917	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.37e-05	0.000874	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.29e-05	0.000858	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PDHA1—stomach cancer	4.27e-05	0.000853	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ECHS1—stomach cancer	4.27e-05	0.000853	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—stomach cancer	4.19e-05	0.000837	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2A6—stomach cancer	4.14e-05	0.000827	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.11e-05	0.000821	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKR1C3—stomach cancer	4.03e-05	0.000805	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FADS1—stomach cancer	4.01e-05	0.000802	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TYMP—stomach cancer	4.01e-05	0.000802	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HSPB1—stomach cancer	3.97e-05	0.000793	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGTR2—stomach cancer	3.97e-05	0.000793	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ENO1—stomach cancer	3.92e-05	0.000784	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BMP2—stomach cancer	3.92e-05	0.000784	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2R—stomach cancer	3.92e-05	0.000784	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.86e-05	0.000771	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKR1C3—stomach cancer	3.86e-05	0.000771	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR1A—stomach cancer	3.82e-05	0.000763	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF2—stomach cancer	3.76e-05	0.000751	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—RORA—stomach cancer	3.71e-05	0.000742	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCB—stomach cancer	3.7e-05	0.000739	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ANXA1—stomach cancer	3.69e-05	0.000737	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—stomach cancer	3.67e-05	0.000733	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB1—stomach cancer	3.57e-05	0.000714	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD44—stomach cancer	3.48e-05	0.000695	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDOB—stomach cancer	3.48e-05	0.000695	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RPS6—stomach cancer	3.41e-05	0.000682	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.38e-05	0.000675	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCB—stomach cancer	3.36e-05	0.000671	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6ST—stomach cancer	3.34e-05	0.000668	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—stomach cancer	3.31e-05	0.000662	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.28e-05	0.000656	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.27e-05	0.000654	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALOX5—stomach cancer	3.23e-05	0.000646	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—DPYD—stomach cancer	3.18e-05	0.000636	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HBEGF—stomach cancer	3.14e-05	0.000627	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.11e-05	0.000622	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6R—stomach cancer	2.98e-05	0.000596	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RHOA—stomach cancer	2.97e-05	0.000593	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPP2R1A—stomach cancer	2.96e-05	0.000591	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—stomach cancer	2.9e-05	0.00058	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRB2—stomach cancer	2.89e-05	0.000578	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.88e-05	0.000576	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—stomach cancer	2.86e-05	0.000572	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP2R1A—stomach cancer	2.84e-05	0.000567	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—stomach cancer	2.81e-05	0.000562	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2A6—stomach cancer	2.78e-05	0.000556	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKR1C3—stomach cancer	2.71e-05	0.000541	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TYMS—stomach cancer	2.7e-05	0.000539	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RHOA—stomach cancer	2.69e-05	0.000539	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—stomach cancer	2.67e-05	0.000533	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ENO1—stomach cancer	2.64e-05	0.000527	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SMAD4—stomach cancer	2.63e-05	0.000526	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—stomach cancer	2.63e-05	0.000525	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—stomach cancer	2.61e-05	0.000521	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.59e-05	0.000518	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ERCC2—stomach cancer	2.51e-05	0.000501	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FYN—stomach cancer	2.5e-05	0.0005	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—stomach cancer	2.47e-05	0.000493	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—stomach cancer	2.37e-05	0.000473	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—stomach cancer	2.36e-05	0.000471	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR2—stomach cancer	2.35e-05	0.000469	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD44—stomach cancer	2.34e-05	0.000467	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.27e-05	0.000453	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—stomach cancer	2.17e-05	0.000435	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—stomach cancer	2.17e-05	0.000434	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS2—stomach cancer	2.15e-05	0.000429	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—stomach cancer	2.08e-05	0.000416	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—stomach cancer	2.08e-05	0.000415	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.08e-05	0.000415	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.99e-05	0.000397	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCB—stomach cancer	1.98e-05	0.000396	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6ST—stomach cancer	1.98e-05	0.000395	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.95e-05	0.00039	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.92e-05	0.000384	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—stomach cancer	1.91e-05	0.000382	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—stomach cancer	1.9e-05	0.000379	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK3—stomach cancer	1.82e-05	0.000363	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TYMS—stomach cancer	1.81e-05	0.000362	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.79e-05	0.000358	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6R—stomach cancer	1.76e-05	0.000352	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK1—stomach cancer	1.73e-05	0.000346	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—stomach cancer	1.73e-05	0.000346	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—stomach cancer	1.72e-05	0.000343	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.68e-05	0.000337	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—stomach cancer	1.65e-05	0.00033	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—stomach cancer	1.65e-05	0.00033	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—stomach cancer	1.64e-05	0.000329	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—stomach cancer	1.63e-05	0.000326	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	1.59e-05	0.000318	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.58e-05	0.000317	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	1.58e-05	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—stomach cancer	1.5e-05	0.000301	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	1.5e-05	0.0003	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	1.47e-05	0.000295	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—stomach cancer	1.46e-05	0.000292	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—stomach cancer	1.46e-05	0.000291	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	1.4e-05	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.4e-05	0.000279	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	1.39e-05	0.000277	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	1.36e-05	0.000273	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	1.33e-05	0.000266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	1.3e-05	0.00026	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUN—stomach cancer	1.3e-05	0.00026	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—stomach cancer	1.28e-05	0.000257	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	1.26e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	1.26e-05	0.000252	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	1.23e-05	0.000246	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—stomach cancer	1.15e-05	0.000231	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	1.14e-05	0.000227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	1.12e-05	0.000225	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—stomach cancer	1.1e-05	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	1.07e-05	0.000215	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—stomach cancer	1.04e-05	0.000209	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	1.02e-05	0.000204	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	1.02e-05	0.000204	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—stomach cancer	1.01e-05	0.000202	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	9.65e-06	0.000193	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—stomach cancer	9.25e-06	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	8.87e-06	0.000177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—stomach cancer	8.58e-06	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	8.2e-06	0.000164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—stomach cancer	7.85e-06	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—stomach cancer	6.22e-06	0.000124	CbGpPWpGaD
